About Deep Genomics Inc.
Deep Genomics is a therapeutics company that brings together a multidisciplinary team of world-leading experts in machine learning, genomics, chemistry, and biology. Together we are on a mission to rapidly discover and develop oligonucleotide drugs for the treatment of patients with disorders of the liver, central nervous system, eye and kidney.
The mission of the target identification team is to leverage the vast amount of genetic data and the Deep Genomics AI Workbench, to identify targets with significant unmet need and offering unique opportunities for oligonucleotide therapeutics development.
Deep Genomics recently closed a series C founding round $180M led by the SoftBank Vision Fund.